27 June 2023 - Commonwealth claims on the damages undertaking remain a live issue for patentees and generics to consider. ...
15 August 2020 - The Federal Court recently issued its decision in Natco v Canada (Minister of Health), 2020 FC 788, ...
23 September 2019 - A group of institutional investors representing more than US$500 billion is calling on the U.S. Congress ...
6 September 2019 - An unlikely answer to the global crisis in antibiotic resistance. ...
21 August 2019 - The global healthcare sector, including Australia, faces increasing cyber threats and malicious activity from Chinese groups, ...
19 October 2018 - The High Court has dismissed the ACCC’s application to appeal a decision on whether Pfizer’s local ...
29 September 2018 - An estimated 8·4 million people worldwide have moderate to severe vision loss caused by age-related macular degeneration. ...
21 September 2018 - The NHS has won a landmark battle against drug giants paving the way for the health ...
19 September 2018 - Cheap copies of Gilead’s HIV drug Truvada, which can also be used to reduce the risk ...
16 June 2018 - Taking an 'asymmetrical' approach and targeting U.S. intellectual property has worked in the past, experts say. ...
26 February 2018 - The NHS could reclaim up to £502 million in excess prescribing costs relating to Pfizer’s pregabalin ...
31 August 2017 - A six-week hearing in the Federal Court of Australia commenced this week to decide whether the Commonwealth ...
30 June 2017 - Canada’s Supreme Court on Friday struck down rules making it easy for generic drug firms to ...
4 April 2017 - As of 1 April 2017, Samsung Bioepis' Brenzys, a biosimilar to Pfizer's Enbrel (etanercept), will join ...
29 March 2017 - In a recent landmark Australian Federal Court decision, Bayer v Generic Health FCA 250, Bayer was awarded ...